Loading...
OTCM
BTCY
Market cap13mUSD
Dec 05, Last price  
0.49USD
1D
8.65%
1Q
-28.99%
Jan 2017
-81.01%
IPO
-81.51%
Name

Biotricity Inc

Chart & Performance

D1W1MN
OTCM:BTCY chart
P/E
P/S
0.99
EPS
Div Yield, %
Shrs. gr., 5y
29.14%
Rev. gr., 5y
57.61%
Revenues
14m
+14.32%
00000398,2001,417,7253,384,7677,650,2699,639,05712,063,34513,790,294
Net income
-8m
L-40.25%
-91,072-90,813-5,185,852-7,809,291-8,623,738-8,592,065-11,066,942-15,491,176-29,130,477-18,658,143-14,094,283-8,421,179
CFO
-2m
L-64.44%
-8,222-26,951-1,963,975-3,748,865-4,874,535-5,220,847-7,862,779-11,080,831-15,163,384-13,547,935-6,693,912-2,380,177

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Biotricity, Inc., a medical technology company, provides biometric data monitoring solutions primarily in the United States. The company focuses on delivery of remote monitoring solutions to medical, healthcare, and consumer markets, including diagnostic and post-diagnostic solutions for lifestyle and chronic illnesses. It offers Bioflux mobile cardiac telemetry solution, an integrated ECG device; and ECG analysis software that analyzes and synthesizes patient ECG monitoring data, as well as software components. The company is based in Redwood City, California.
IPO date
Oct 26, 2015
Employees
55
Domiciled in
US
Incorporated in
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2025‑032024‑032023‑032022‑032021‑032020‑032019‑032018‑032017‑032015‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT